TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Linan ZhuXudong ZhangXiaorui FuZhaoming LiZhenchang SunJingjing WuXinhua WangFeng WangXiangke LiSongtao NiuMengjie DingZhenzhen YangWanqiu YangMeifeng YinLei ZhangMing-Zhi ZhangPublished in: Journal of translational medicine (2018)
These results suggest that TIPE2 suppressed progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.